Charming Medical Appoints Audit Expert Mei Cai to Board, Tsui Resigns
MCTA has more than doubled off its 52-week low of $4.3 on elevated volume (4.9× avg).
Summary
Charming Medical announced the resignation of an independent director and the appointment of Ms. Mei Cai, an experienced financial expert, to its board and as Audit Committee Chair.
Key Events · Executive and Board Changes · MCTA
-
Independent Director Resigns
Mr. Matthew Mo Kan Tsui resigned as an independent director, effective April 27, 2026, citing other business commitments. The company confirmed his resignation was not due to any disagreement.
-
New Independent Director Appointed
Ms. Mei Cai was appointed as an independent director, effective May 2, 2026. She brings over 20 years of experience in accounting, auditing, SEC reporting, and corporate finance.
-
Audit Committee Chair Designated
Ms. Cai has been named the chairman of the Audit Committee and a member of the Compensation and Nominating Committees. She qualifies as an "audit committee financial expert" under SEC rules.
Analysis · MCTA · Industrial Applications And Services
Charming Medical has appointed Ms. Mei Cai, a highly experienced financial professional, as an independent director and the new chairman of its Audit Committee. Her designation as an "audit committee financial expert" and extensive background in SEC reporting and corporate finance are significant governance enhancements. This appointment follows the resignation of Mr. Matthew Mo Kan Tsui, which the company stated was due to other business commitments and not disagreements.
At the time of this filing, MCTA was trading at $29.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $438.5M. The 52-week trading range was $4.30 to $31.70. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.